Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Medicina Clinica|July 19, 2025
Cancer of unknown primary: Diagnosis, treatment and technological advancesFerran Losa Gaspà, Raquel Legido Díaz, Sheila Sánchez Pérez
Medicina Clinica|April 10, 2009
[Colorectal cancer in a population with a guaiac-based screening programme]Matilde Navarro, Mercè Peris, Gemma Binefa, et al.
International Journal of Colorectal Disease|June 1, 2023
Determining the optimal interval between neoadjuvant radiochemotherapy and surgery in rectal cancer: a retrospective cohort studyMaria Cambray, Javier González-Viguera, Ferran Losa, et al.
Clinical and Translational Gastroenterology|June 23, 2020
Short-Course Radiotherapy in Locally Advanced Rectal CancerMaria Cambray, Javier Gonzalez-Viguera, Miguel Angel Berenguer, et al.
Anti-Cancer Drugs|October 1, 2004
Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) according to toxicity prognostic factorsEugeni Saigi, Antonieta Salut, Juan Manuel Campos, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|December 26, 2018
[2018 Consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary]Xavier Matías-Guiu, Victòria Fusté, Lara Iglesias, et al.
Cancers|February 15, 2022
Spatial Immunology in Liver Metastases from Colorectal Carcinoma according to the Histologic Growth PatternGemma Garcia-Vicién, Artur Mezheyeuski, Patrick Micke, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2023
Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statementCristina Grávalos, Fernando Pereira, Ruth Vera, et al.
The Oncologist|April 7, 2011
Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS studyMiguel Nogué, Antonieta Salud, Pilar Vicente, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancerRamon Salazar, Matilde Navarro, Ferran Losa, et al.
Pageof 3